Recent research findings shed light on the significant impact of infectious diseases on global cancer cases. According to a study conducted by the International Agency for Research on Cancer, approximately 12 percent of new cancer cases worldwide in 2024 were attributed to infectious agents, including viruses and bacteria.
This revelation highlights the potential for prevention, indicating that a considerable portion of the global cancer burden is preventable. With the existing preventative measures and vaccines, there exists an opportunity to effectively reduce these cancer cases caused by infections.
Researchers emphasize the importance of utilizing available tools like vaccines and other preventive strategies to combat infectious agents. By implementing these health measures, it is possible to significantly decrease the incidence of cancer associated with infectious diseases, offering an optimistic outlook on reducing overall cancer rates.
Notably, Helicobacter pylori bacteria has been identified as one such infectious agent with the potential to cause cancer. Continued advancement in medical research and public health strategies is crucial in tackling the preventable nature of these cancer cases.
Americans’ Confidence in Federal Food Safety Drops to Record Low 
Flu Season Hits Early: Importance of Timely Vaccination 
Exploring the Potential of GLP-1 Drugs Beyond Weight Loss 
Veterans to Receive 3.6 Percent Increase in Disability Compensation in 2027 
FDA Issues Class I Recall for Dozens of Salad Products Due to Listeria Risk 
Toxic Metal Exposure in Maui Fire Survivors